ORANGE COUNTY, Fla. – A wide variety of elections took place in Orange County on Tuesday, March 10. Residents from Apopka to Winter Park casted ballots on commissioner, mayoral and council seat ...
Good day, and welcome to the Tango Therapeutics conference call. [Operator Instructions] Please note, this call is being recorded. I'd now like to turn the call over to Liz Hickin, Vice President, ...
A shift in the way people think about and treat pancreatic cancer could be on the horizon based on positive results from the pivotal randomized phase 3 RASolute 302 trial comparing daraxonrasib to ...
Tri-complex inhibitors (TCIs) are molecular glues that bind to active GTP-bound RAS and recruit the intracellular chaperone cyclophilin A (CYPA) to generate a synthetic inhibitory complex that blocks ...
Primary contests will be held in six states on Tuesday. We’ll be paying close attention to California, where dozens of candidates are vying to replace Gov. Gavin Newsom in an open primary. Here’s what ...
Mayor Karen Bass is facing two main challengers from opposite ends of the political spectrum: Nithya Raman, a liberal City Council member and former ally of the mayor, and Spencer Pratt, a Republican ...
This year’s meeting of the American Society of Clinical Oncology is abuzz with talk of RAS inhibitors, largely driven by Revolution Medicines’ barnburner pancreatic cancer data drop earlier this year.
At the ASCO annual meeting, Dana-Farber’s Brian Wolpin, MD, MPH, will present positive results from the RASolute 302 trial showing a substantial prolongation of survival for patients with previously ...
The targeted RAS inhibitor daraxonrasib was found to be safe and showed signs of efficacy in patients with previously treated RAS-mutant metastatic pancreatic cancer, according to a Phase I/II ...
Dana-Farber investigators and colleagues across the country report from a clinical trial of a RAS(ON) multi-selective inhibitor in pancreatic cancer, given as a daily pill, showing that the drug is ...
President Donald Trump and MAGA-aligned financial backers supported challengers to seven GOP state senators in primaries. The seven incumbents drew Trump’s ire in December when they helped defeat a ...